Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $3,349 - $4,757
2,658 Added 17.28%
18,043 $30,000
Q3 2023

Nov 14, 2023

BUY
$1.61 - $2.54 $6,048 - $9,542
3,757 Added 32.31%
15,385 $27,000
Q2 2023

Aug 14, 2023

SELL
$1.14 - $1.95 $1,582 - $2,706
-1,388 Reduced 10.66%
11,628 $21,000
Q1 2023

May 12, 2023

SELL
$1.2 - $2.19 $96 - $175
-80 Reduced 0.61%
13,016 $17,000
Q4 2022

Feb 09, 2023

BUY
$1.63 - $3.52 $5,630 - $12,158
3,454 Added 35.82%
13,096 $22,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $7,038 - $36,061
9,642 New
9,642 $30,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.